Tag: immunotherapeutic

spot_imgspot_img

Immutep: Invests nearly $30M for ongoing clinical trials

Biotech company Immutep (IMM) has tapped institutional investors for a neat $29.6 million to fund its cancer and autoimmune diseases treatment trials The...